/PRNewswire/ The European Investment Bank (EIB) has awarded a €7.5 million loan to Diadem Srl, a company developing the first blood-based prognostic test.
The Italian startup expects to make its AlzoSurePredict biomarker-based blood test for early Alzheimer's disease detection available in the EU later this year.
/PRNewswire/ The European Investment Bank (EIB) has awarded a €7.5 million loan to Diadem Srl, a company developing the first blood-based prognostic test.
European Investment Bank to Provide a €7.5 Million Loan to Support Further Research and Development of Diadem's AlzoSure® Predict Blood Test for Alzheimer's Disease - read this article along with other careers information, tips and advice on BioSpace